亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial

医学 血管成形术 动脉切除术 随机对照试验 气球 外科 切割气球 再狭窄 放射科 支架
作者
Aljoscha Rastan,Marianne Brodmann,Tanja Böhme,Roland Macharzina,Elias Noory,Ulrich Beschorner,Peter-Christian Flügel,Karlheinz Bürgelin,Franz‐Josef Neumann,Thomas Zeller
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
卷期号:14 (6) 被引量:23
标识
DOI:10.1161/circinterventions.120.010280
摘要

Background: Prospective, randomized, multicenter trials show no beneficial impact of drug-coated balloon (DCB) therapy alone on the technical and clinical outcomes of infrapopliteal artery lesions in comparison to plain old balloon angioplasty. The aim of this study was to evaluate the performance of directional atherectomy (DA) plus DCB angioplasty versus DCB alone in treatment of long infrapopliteal artery lesions. Methods: We conducted a prospective, randomized, 2-center trial comparing the performance of DA+DCB and DCB alone in treatment of 80 patients with de novo infrapopliteal artery lesions. The primary study end point was the 6-month primary patency of the target lesion detected by angiography and duplex ultrasound. Secondary end points included clinically driven target vessel revascularization, amputation rates, and changes in Rutherford-Becker class at 1 year. A core laboratory provides independent analyses for all scheduled and unscheduled duplex ultrasound examinations and angiographies, and a research institute ensured independent data collection. Results: The mean target lesion length was 179.7±98.2 mm. Nine patients (11.3%) died during the follow-up period. At 6 months, primary patency was 49% (n=18) with DA+DCB versus 34% (n=12) with DCB alone ( P =0.241), and clinically driven target vessel revascularization was 8% (n=3) versus 14% (n=5; P =0.475), respectively. At 1 year, the target lesion revascularization rates were 30% (n=10) versus 43% (n=12; P =0.308), the median in Rutherford-Becker class was 2 (0.25–5) versus 5 (0.25–5; P =0.329), and amputation rates were 22% (n=8) versus 32% (n=11; P =0.618) in the DA+DCB group and the DCB group, respectively. Conclusions: Treatment of long infrapopliteal artery lesions with DA+DCB versus DCB alone leads to comparable clinical and technical results at 6 months and 1 year. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01763476.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Dr.Tang完成签到 ,获得积分10
3秒前
搜集达人应助WATeam采纳,获得10
7秒前
斯文的苡完成签到,获得积分10
9秒前
jyy完成签到,获得积分10
9秒前
tta发布了新的文献求助10
11秒前
头孢西丁完成签到 ,获得积分10
12秒前
willlee完成签到 ,获得积分10
12秒前
13秒前
Cain驳回了顾矜应助
15秒前
HCB1发布了新的文献求助10
18秒前
ceeray23发布了新的文献求助20
22秒前
22秒前
Akim应助拼搏的二哈采纳,获得10
30秒前
33秒前
hob完成签到,获得积分10
33秒前
凉的白开完成签到,获得积分10
34秒前
weixiaosi完成签到 ,获得积分10
37秒前
WATeam发布了新的文献求助10
38秒前
40秒前
leave完成签到 ,获得积分10
40秒前
明理晓霜发布了新的文献求助10
45秒前
48秒前
可爱的函函应助酷酷白萱采纳,获得10
49秒前
酷酷白萱完成签到,获得积分20
59秒前
1分钟前
无花果应助ceeray23采纳,获得20
1分钟前
棣棣完成签到,获得积分10
1分钟前
00完成签到,获得积分10
1分钟前
c2发布了新的文献求助10
1分钟前
小汤完成签到,获得积分20
1分钟前
舟舟完成签到 ,获得积分10
1分钟前
linkman发布了新的文献求助10
1分钟前
linkman发布了新的文献求助30
1分钟前
linkman发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
003完成签到,获得积分10
1分钟前
Splaink完成签到 ,获得积分10
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990012
求助须知:如何正确求助?哪些是违规求助? 3532068
关于积分的说明 11256227
捐赠科研通 3270933
什么是DOI,文献DOI怎么找? 1805123
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216